NaviFUS Corp.

NaviFUS Corp. is a biotechnology company specializing in the development of advanced medical devices that harness focused ultrasound technology for the treatment of neurological disorders. The company's principal innovation, the NaviFUS System, is a neuronavigation-guided transcranial focused ultrasound platform designed to non-invasively open the blood-brain barrier, thereby enhancing the delivery of therapeutics—including oncology drugs—directly to targeted brain regions with high precision. This capability addresses critical challenges in treating central nervous system (CNS) diseases and brain tumors by facilitating improved drug penetration and therapeutic outcomes. NaviFUS also develops NAVIRFA, an optical 3D needle tracking system for image-guided interventional procedures. Collaborating with leading hospitals and global partners, NaviFUS Corp. is actively engaged in clinical trials for conditions such as recurrent brain tumors and epilepsy, and is expanding applications to other neurological diseases like Alzheimer’s. By integrating Taiwan’s advanced chip technology and leveraging its expertise in ultrasound, NaviFUS plays a significant role in advancing non-invasive, precision medicine solutions within the healthcare sector.